Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Kronenberg, Mohammed
DOB: 03-MAY-1938 (Age: 87)
Gender: male
ID: 2349-780991-5 (ECI)
Author
dr van Oosten, Olaf
Patient summary Document
European Patient Summary
Report Date: 15-FEB-2023

Problem list

Condition Onset Date / Period Status
Acute bacterial sinusitis 15-Jul-2025 active
Carcinoma in situ of prostate 19-Nov-2014 active
Neoplasm of prostate 19-Nov-2014 active
Anemia 23-Apr-2014 active
Proteinuria due to type 2 diabetes mellitus 01-May-2013 active
Microalbuminuria due to type 2 diabetes mellitus 07-Oct-2009 active
Ischemic heart disease 01-Oct-2008 active
Disorder of kidney due to diabetes mellitus 14-Sep-2005 active
Acute ST segment elevation myocardial infarction 14-Feb-2003 active
Sleep apnea 08-Dec-1976 active
Sleep disorder 22-Nov-1976 active
Essential hypertension 24-Mar-1976 active
Acute viral pharyngitis 25-Nov-2023 - 06-Dec-2023 inactive
Fracture of clavicle 16-Sep-2023 - 18-Nov-2023 inactive
Fracture of bone 16-Sep-2023 - 18-Nov-2023 inactive
Viral sinusitis 03-Nov-2021 - 26-Nov-2021 inactive
Acute bronchitis 21-Jun-2019 - 04-Jul-2019 inactive
Fracture of bone 30-Nov-2016 - 26-Jan-2017 inactive
Closed fracture of hip 30-Nov-2016 - 26-Jan-2017 inactive
Chronic kidney disease stage 4 05-Nov-2014 - 21-Jun-2017 inactive
Chronic kidney disease stage 3 01-May-2013 - 21-Jun-2017 inactive
Chronic kidney disease stage 2 07-Oct-2009 - 21-Jun-2017 inactive
Chronic kidney disease stage 1 14-Sep-2005 - 21-Jun-2017 inactive

Medication list

Medication Since Form Dosage Reason
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-02-26 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2025-02-26 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Tacrolimus 1 mg prolonged-release oral tablet 2025-02-26 - 1 tablet (1 mg) once daily History of renal transplant (situation)
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 2008-10-08 - 1 tablet (75 mg) by mouth once daily -
Simvastatin 20 mg oral tablet 2008-10-08 - 1 tablet (20 mg) by mouth once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 2008-10-08 - 400 micrograms (1 spray) sublingually as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 2008-10-08 - 1 tablet (100 mg) once daily -
Aspirin 81 mg gastro-resistant oral tablet 2003-02-14 - 1 tablet (81 mg) by mouth once daily -
Atorvastatin (as atorvastatin calcium) 20 mg oral tablet 2003-02-14 - 1 tablet (20 mg) once daily -
Metoprolol tartrate 25 mg oral tablet 2003-02-14 - 1 tablet (25 mg) by mouth twice daily -
Nicotine 291.667 microgram/hour prolonged-release transdermal patch 1962-02-07 - Apply one patch (291.667 microgram/hour) once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 26-Feb-2025
SARS-CoV-2 mRNA vaccine 24-Feb-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 28-Nov-2018

Procedure History list

Procedure Date Reason
Plain X-ray of clavicle 16-Sep-2023 -
Admission to orthopedic department 16-Sep-2023 Fracture of clavicle (disorder)
Bone density scan 16-Sep-2023 Fracture of clavicle (disorder)
Patient discharge 29-Jan-2022 -
Hospice care 28-Jan-2022 -
Notifications 08-Dec-2021 -
Certification procedure 08-Dec-2021 -
Initial patient assessment 08-Dec-2021 -
Development of individualized plan of care 08-Dec-2021 -
Screening for substance abuse 20-Oct-2021 -
Assessment of health and social care needs 20-Oct-2021 -
Screening for domestic abuse 20-Oct-2021 -
Assessment of substance use 20-Oct-2021 -
Sleep apnea assessment 03-Jul-2019 Sleep disorder (disorder)
Assessment using Morse Fall Scale 03-Jul-2019 -
Transplantation of kidney regime 23-Jun-2017 History of renal transplant (situation)
Transplant of kidney 21-Jun-2017 Awaiting transplantation of kidney (situation)
Pretransplant evaluation of kidney recipient 21-Jun-2017 Awaiting transplantation of kidney (situation)
Plain X-ray of pelvis 30-Nov-2016 -

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Cancer care plan 19-Nov-2014 Neoplasm of prostate (disorder)
  • Achieve remission or optimal control of prostate cancer as per oncology recommendations
  • Maintain or reduce PSA to target level as determined by oncology
  • Minimize urinary, pain, or other symptoms related to prostate cancer to improve quality of life
Dialysis care plan 26-Apr-2014 -
Discharge care plan 14-Feb-2003 -
Lifestyle education regarding hypertension 24-Mar-1976 Essential hypertension (disorder)
  • Patient will implement recommended lifestyle modifications to help control blood pressure.
Care plan 07-Feb-1962 Sleep apnea (disorder)
  • Reduce the number of apnea and hypopnea events per hour of sleep to improve sleep quality and reduce cardiovascular risk.
Immunization Recommendation Due Date Reason
Influenza virus antigen only vaccine product 01-Oct-2026 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-02-26 2024-02-21
Body Height 175.4 cm 175.4 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} 1 {score}
Body Weight 92.9 kg 92.9 kg
Body mass index (BMI) [Ratio] 30.2 kg/m2 30.2 kg/m2
Heart rate 98 /min 68 /min
Respiratory rate 14 /min 14 /min
Blood pressure panel with all children optional 82 mm[Hg] 85 mm[Hg]

Relevant diagnostic tests/laboratory data

Recent Lab Observations 15-FEB-2023 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 206.8 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 115.9 0 - 149 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 154.2 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 29.5 L 40 - 60 mg/dL

Device Use

Device Date (since)
Home continuous positive airway pressure unit (physical object) 26-Feb-2025
Respiratory humidifier (physical object) 26-Feb-2025